Dr Lalchandani Labs share news and announcements
BSE: 541299Healthcare ServicesSmall Cap
Last close ₹6.96down ₹0.19 (2.66%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹7.15.
52-week range of traded prices to 23 Oct 2026
₹5.81Low, 9 Oct 2026₹23.69High, 12 Jan 2026
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6.01 Cr4,613th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 3 Jun 2026
- 94.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 3 Jun 2026
- 0.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 3 Jun 2026
- 0.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 3 Jun 2026
- 0.15
- Volume, BSEVolume. Shares traded on the last trading day.
- 44,000
Dr Lalchandani Labs board meetings
77 filed, newest first. Page 1 of 2.
May 2026
27 May · Board meeting
Meeting on 30 May 2026: audited results
Mar 2026
Feb 2026
Jan 2026
20 Jan · Board meeting
Meeting on 20 Jan 2026: rights issue of equity shares and rights issue
Dec 2025
16 Dec · Board meeting
Meeting on 22 Dec 2025: rights issue15 Dec · Board meeting
Meeting on 15 Dec 2025: rights issue of equity shares9 Dec · Board meeting
Meeting on 9 Dec 20259 Dec · Board meeting
Nov 2025
10 Nov · Board meeting
Meeting on 14 Nov 2025: half yearly results
Sep 2025
5 Sep · Board meeting
Apr 2025
25 Apr · Board meeting
Meeting on 1 May 2025: audited results
Oct 2024
14 Oct · Board meeting
8 Oct · Board meeting
Meeting on 14 Oct 2024: half yearly results
Sep 2024
7 Sep · Board meeting
May 2024
21 May · Board meeting
Meeting on 30 May 2024: audited results
Nov 2023
14 Nov · Board meeting
7 Nov · Board meeting
Meeting on 14 Nov 2023: half yearly results
Sep 2023
8 Sep · Board meeting
Jun 2023
May 2023
30 May · Board meeting
Meeting on 19 Jun 2023: audited results
Nov 2022
10 Nov · Board meeting
Meeting on 14 Nov 2022: half yearly results
Sep 2022
May 2022
23 May · Board meeting
Meeting on 30 May 2022: audited results
Mar 2022
9 Mar · Board meeting
Meeting on 9 Mar 20229 Mar · Board meeting
Nov 2021
3 Nov · Board meeting
Meeting on 12 Nov 2021: half yearly results
Sep 2021
Jul 2021